CRWV Form 144 Filed for 50,000 Founder Shares Sale via Morgan Stanley

Rhea-AI Filing Summary

Form 144 notice by an insider for CoreWeave, Inc. (CRWV) reports a proposed sale of 50,000 shares of common stock, acquired as founders' shares on 11/13/2017. The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services in New York. The filer states an aggregate market value of $4,569,500 and notes total shares outstanding of 370,470,348. The approximate date of sale is 08/27/2025. The notice indicates no securities sold by the reporting person in the past three months and includes the required representation that the seller is not aware of any undisclosed material adverse information.

Positive

• Full disclosure of required Rule 144 details: security class, acquisition date, nature (founders' shares), broker, amount, and aggregate market value are provided
• No sales in prior three months reported, simplifying aggregation requirements under Rule 144

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Form 144 filing disclosing a proposed sale of founder shares through a broker; paperwork appears complete for Rule 144 purposes.

The filing documents a proposed sale of 50,000 founder shares acquired on 11/13/2017 using Morgan Stanley Smith Barney LLC as broker, with an aggregate market value reported at $4,569,500 and an approximate sale date of 08/27/2025. The filer declares no sales in the prior three months and affirms absence of undisclosed material adverse information. From a compliance perspective, the filing contains the standard elements required by Rule 144: security class, acquisition date and nature, broker name, amount to be sold, and representation statements. The filing does not provide additional context such as relationship to the issuer or any lock-up/holding period details, which are not present in the document.

Market Impact Analyst

TL;DR: Disclosure of a single proposed sale of 50,000 shares is informational and unlikely to be materially impactful given the issuer's total outstanding shares.

The document reports 50,000 shares to be sold against 370,470,348 shares outstanding. The reported aggregate market value is $4,569,500. The filing explicitly states there were no sales in the past three months by the reporting person. Based solely on the figures provided, the proposed sale represents a small fraction of outstanding shares. The filing does not include any forward-looking statements or operational data that could alter market interpretation beyond the disclosed transaction details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	4569500.00	370470348	08/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CoreWeave (CRWV) disclose?

The notice discloses a proposed sale of 50,000 common shares acquired as founders' shares on 11/13/2017, to be sold via Morgan Stanley Smith Barney LLC with an approximate sale date of 08/27/2025 and aggregate market value of $4,569,500.

How large is the proposed sale relative to CoreWeave's outstanding shares?

The filing lists 370,470,348 shares outstanding; the proposed 50,000 share sale is a small fraction of that total.

Did the filer report any other sales of CoreWeave stock in the past three months?

No. The filing states Nothing to Report for securities sold in the past three months by the reporting person.

What type of shares are being sold according to the Form 144?

The securities are listed as Common shares and were acquired as Founders' Shares on 11/13/2017.

Does the filing state the seller knows of any undisclosed material information?

Yes. By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.